Medpace 

€319.7
116
-€0.1-0.03% 오늘

통계

낮 최고
319.7
낮음
319.7
52W 높음
-
52W 낮음
-
거래량
0
평균 거래량
-
시가 총액
9.84B
주가수익률
33
배당수익률
-
배당금
-

예정

수익

21Oct예상
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
다음
1.8
2.27
2.73
3.2
예상 EPS
2.794971
실제 EPS
해당 없음

다른 인물도 팔로우하고 있습니다

이 목록은 Stock Events에서 01P.F을(를) 팔로우하는 사람들의 워치리스트에 기반한 것입니다. 이는 투자 권유가 아닙니다.

경쟁자

이 목록은 최근 시장 이벤트에 기반한 분석입니다. 투자 권장사항이 아닙니다.

개요

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
CEO
Dr. August James Troendle M.D.
직원
5800
국가
US
ISIN
US58506Q1094
WKN
000A2APTV

목록